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Abstract: In the present study, two open porous calcium
phosphate ceramics, b-tricalcium phosphate (b-TCP), and
hydroxyapatite (HA) were compared in a critical-sized femoral
defect in rats. Previous comparisons of these two ceramics
showed significantly greater osteoinductive potential of b-
TCP upon intramuscular implantation and a better perform-
ance in a spinal fusion model in dogs. Results of the current
study also showed significantly more bone formation in
defects grafted with b-TCP compared to HA; however, both
the ceramics were not capable of increasing bone formation
to such extend that it bridges the defect. Furthermore, a
more pronounced degradation of b-TCP was observed as
compared to HA. Progression of inflammation and initiation
of new bone formation were assessed for both materials at
multiple time points by histological and fluorochrome-based
analyses. Until 12 days postimplantation, a strong inflamma-
tory response in absence of new bone formation was
observed in both ceramics, without obvious differences
between the two materials. Four weeks postimplantation,
signs of new bone formation were found in both b-TCP and
HA. At 6 weeks, inflammation had subsided in both ceramics
while bone deposition continued. In conclusion, the two
ceramics differed in the amount of bone formed after 8
weeks of implantation, whereas no differences were found in
the duration of the inflammatory phase after implantation or
initiation of new bone formation. VC 2013 Wiley Periodicals, Inc. J
Biomed Mater Res Part A: 102A: 1399–1407, 2014.
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ductive potential, rat femoral defect, inflammatory response
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INTRODUCTION
Autologous bone is currently the gold standard for grafting
bone defects. However, the limited availability and post-
operative complications associated with the harvesting proce-
dure site have necessitated the search for bone graft substi-
tutes.1 Substitute materials, such as calcium phosphate (CaP)
ceramics, have been used in a widespread of trauma and ortho-
pedic related indications.2,3,5 The interest in CaP ceramics can
be attributed to their chemical resemblance with bone mineral
and their osteoconductivity.4 However, unless additionally
endowed with a osteoinductive stimulus, the general perform-
ance of CaP ceramics remains inferior to autologous bone.
Osteoinductivity is the ability of a material to induce dif-
ferentiation of progenitor cells into the osteogenic lineage
to form active osteoblasts.15 Differentiation into active
osteoblasts is induced through secretion of osteoinductive
factors such as bone morphogenetic proteins. Addition of
osteoinductive factors was therefore thought to be essential
to enhance the performance of CaP ceramics. More recently,
it was found that some open porous CaP ceramics could
induce bone formation in the absence of any osteoinductive
factors, making these CaP ceramics potentially suitable as
off-the-shelf alternatives to autologous bone grafts.6–9
The osteoinductive performance of open porous CaP
ceramics, however, varies strongly and is influenced by
chemical composition and structure (e.g., macroporosity,
microporosity, surface concavities, surface area, and rough-
ness), as recently reviewed.10 Four different CaP ceramics
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were developed and tested in vivo by our group.16 Open
porous CaP ceramic particles (1–2 mm) tested were b-
tricalcium phosphate (b-TCP) ceramic with a specific surface
area of 1.2 m2/g, phase-pure hydroxyapatite (HA) ceramic
with specific surface area of 0.1 m2/g and two biphasic
ceramics both consisting of HA and b-TCP in a weight ratio
80:20, but sintered at different temperatures to vary micro-
structural properties and specific surface area (1 vs 0.2 m2/
g). Twelve weeks after implantation in canine paraspinal
muscles (1 mL of ceramic particles) and spinal fusion
regions (5 mL of ceramic particles), the largest difference
was found between b-TCP and HA. b-TCP gave five times
more bone in both paraspinal muscles (0 vs 20% area
of available pore space covered with bone) and spinal
fusion regions (5 vs 25% area of available pore space cov-
ered with bone).
Implantation at ectopic sites (e.g. intramuscular or sub-
cutaneous) is an established method to screen materials
osteoinductive properties since seminal work by Urist11 in
the 1960s. However, extrapolating this data to clinically rel-
evant bone defects requires evaluation in clinically more rel-
evant models. As bone is not naturally present at the site of
bone formation in spinal fusion models, this model cannot
be considered fully orthotopic and it remains to be further
elucidated whether the osteoinductive performance of b-
TCP is relevant in critical-sized orthotopic bone defects. Fur-
thermore, the osteoinductive performance of b-TCP may be
the effect of faster degradation and release of microparticles
altering the intrinsic inflammatory phase reaction before
bone formation.12–14 Others have shown that bone forma-
tion benefits from a mild contained inflammatory reaction,
and strong inflammatory reactions can make the environ-
ment hostile, and hamper bone formation.20
The aim of the current study was to determine whether
the osteoinductive performance of b-TCP is relevant to bone
formation in a critical-sized cortical bone defect in rats,
compared to the less osteoinductive HA. Furthermore, we
aimed to determine the duration of the inflammatory
response within this bone defect model after implantation
of b-TCP and HA, to assess whether the duration of the
inflammatory response could be related to bone formation.
MATERIALS AND METHODS
Synthesis and characterization of HA
and b-TCP ceramics
In this study two CaP ceramics were investigated: HA and
b-TCP. The HA ceramic was prepared from HA powder
(Merck) using the dual phase mixing method20 consisting of
three steps. First, HA slurry was prepared by mixing 2/3 wt
% of calcined HA powder with 1/3 wt % water containing
deflocculant (dolpix CE 64, Germany) and binder (carboxyl-
methyl cellulose; Pomosin BC, the Netherlands). Then, two
immiscible phases were mixed: water-based HA slurry and
polymethylmethacrylate (PMMA) resin with a volume ratio
of 1:1. The PMMA resin consisted of PMMA powder, methyl-
methacrylate (MMA) monomer, and naphthalene (<10%, v/
v) as an additional fugitive pore maker. Finally, the mixture
was polymerized, dried and pyrolized and sintered at
1250C for 8 h. The b-TCP ceramic was fabricated by the
H2O2 method as described previously
21 using b-TCP powder
purchased from Plasma Biotal (Derbyshire, UK). The powder
was mixed with 2% H2O2 solution (1.0 g powder/1.20 6
0.05 mL solution) and naphthalene particles (710–1400 mm;
100 g powder/30 g; Fluka Chemie, Zwijndrecht, the Nether-
lands) at 60C. The naphthalene was then evaporated at
80C and the porous bodies were dried, and sintered at
1100C for 8 h. For both CaP ceramics, a lathe was used to
produce the cylinders. Subsequently, the cylinders were cut
into implants 6 mm in length and 3 mm in diameter.
Implants were cleaned ultrasonically with acetone, 70%
ethanol and demineralized water, dried at 80C, and steri-
lized by gamma irradiation before implantation.
The chemical composition and the crystallinity of the
ceramics were analyzed using X-ray diffraction (Miniflex,
Rigaku, Japan). The macropore size and porosity of the CaP
ceramics were determined by image analysis on thin sec-
tions using a KS400 image system (Carl Zeiss, Germany)
attached to a light microscope (LM, objective, 310; Nikon,
Japan). Thin sections were made on a Leica diamond saw
after embedding CaP ceramics blocks in MMA. The micro-
structure was evaluated as described previously using a
scanning electron microscope (XL30, Environmental SEM-
Field Emission Gun, Philips). Specific surface area of the
two ceramics was analyzed by mercury intrusion (Microme-
ritics Instrument).
Animal experiment
In total, 34 skeletally mature 18-week-old male Wistar rats
were used on approval by the institution’s Animal Ethics
Committee (EUR2317). Animals were housed according to
national guidelines for the care and use of laboratory ani-
mals. A 6-mm femoral bone defect was grafted with either
HA (n 5 14), b-TCP (n 5 14), or left empty (n 5 6).
The surgical procedures were performed aseptically on a
heated plate under general anesthesia (isoflurane 1–3.5% in
air). Before surgery, the rats received a subcutaneous injec-
tion of buprenorphine (0.3 mg/mL Temgesic; Schering-Plough
B.V., Amstelveen, the Netherlands) at a dose of 0.05 mg/kg
body weight and enrofloxacine (25 mg/mL Baytril; Bayer
B.V., Mijdrecht, the Netherlands) at a dose of 5 mg/kg body
weight. The right thigh was shaved and disinfected with poly-
dine tincture. Then, the femur shaft was exposed by a longi-
tudinal skin incision, and blunt dissection of the underlying
fascia between the vastus lateralis muscle and the biceps
femoris muscle. Next, a 23 mm PEEK plate (RatFix Plate,
RISystem; AO Foundation, Davos, Switzerland) was fixated
onto the anterolateral side of the femur by three cortical and
three distal screws (6.5 mm 3 0.8 mm Ø ShoulderScrews,
RISystem; AO Foundation). Two osteotomies were performed
using a saw guide with a wire saw (Drill&Saw guide, RISys-
tem; AO Foundation) to remove a 6 mm large bone segment.
The resulting defect was then grafted with one of the
implants or left empty (Fig. 1). The wound was irrigated
with sterile saline and sutured with 5-0 Vicryl sutures. Post-
operative care consisted of subcuteaneous administration of
1400 CHATTERJEA ET AL. POROUS CALCIUM PHOSPHATE CERAMICS IN BONE DEFECTS
buprenorphine (0.3 mg/mL Temgesic, 0.05 mg/kg body
weight) as analgesia twice a day for the first 3 days.
To visualize the dynamics of bone growth, rats received
sequential subcutaneous injections with fluorochrome labels
at 4 weeks [12.5 mg/mL calcein green (CG), 10 mg/kg body
weight; Sigma Aldrich, Zwijndrecht, the Netherlands] and 6
weeks [50 mg/mL xylenol orange (XO), 100 mg/kg body
weight, Sigma Aldrich].
To qualitatively assess the duration of the inflammatory
response, two animals from the HA and the b-TCP group
were sacrificed after 5 and 12 days, whereas one animal from
of each group was sacrificed after 6 weeks. To quantify bone
formation, the remaining nine animals in the groups that
received either HA or b-TCP were scarified after 8 weeks.
Another six animals in whom the defect was left empty were
included to confirm the critical size of the defect.
Microcomputed tomography evaluation
Microcomputed tomography (micro-CT) scans were
acquired to provide a qualitative overview of bone integra-
tion and resorption of the CaP ceramics and to confirm the
critical size of the defect. Right femurs were collected, fix-
ated in formalin (Merck chemicals; the Netherlands) and
kept hydrated during the scanning process by wrapping
them in foil. A SkyScan 1076 micro-CT scanner (Bruker
micro-CT N.V., Kontich, Belgium) was used with an 18 mm-
resolution protocol (70 kV energy, 100 mA current, 1.0 mm
Al/0.25 mm Cu filter). CT images were converted into
three-dimensional reconstructions of cross-sectional images
using volumetric reconstruction software NRecon version
1.5 (Bruker micro-CT N.V.).
Histology and histomorphometry
After micro-CT scanning, fixated samples were kept over-
night, dehydrated within an industrial microwave using JFC
solution (Leica Microsystems, Rijswijk, the Netherlands) and
transferred into MMA solution (L.T.I., Bilthoven, the Nether-
lands) and polymerized at 37C within 3 days. Sections
were made at every level of the sample with an approxi-
mate thickness of 10–15 mm using a modified interlocked
diamond saw (Leica Microtome, Nussloch, Germany). Sec-
tions were either stained with 1% methylene blue (Sigma)
and 0.3% basic fuchsin (Sigma) after etching with an HCl/
ethanol mixture for routine histology and histomorphometry
or left unstained for epifluorescence microscopy with a LM
(E600, Nikon) equipped with a quadruple filter block (XF57,
dichroic mirror 400, 485, 558, and 640 nm; Omega Filters,
Didam, the Netherlands).
Histological sections were qualitatively analyzed by light
microscopy (Leica), and each section was scored either posi-
tive or negative for bone formation. For quantitative histo-
morphometry, high-resolution digital photographs were
made from three randomly selected sections from each sam-
ple. Bone and CaP ceramic were manually pseudocolored
green and red, respectively, using Photoshop CS2 (Adobe
Systems). A custom-made Matlab script was used to mea-
sure the percentage of bone in the available pore area in
the total region of implant as well as in the central area of
the implant. The central area was defined as the area cov-
ered by a rectangle drawn along the points 1 mm on either
side of the horizontal line running through the center of the
implant and 2 mm on either side of the vertical line running
through the center of the implant (Fig. 5). For statistical
analysis, a two sided paired Student’s t-test was used to
analyze differences between b-TCP and HA.
RESULTS
Characterization of HA and b-TCP ceramics
HA and b-TCP ceramics similar to those used in our previ-
ous study were produced.16 Chemical and structural charac-
teristics of the two ceramics are presented in Table I.
Micro-CT evaluation
Micro-CT scans showed that none of the six empty defects
(control group) show bridging within the 8 weeks implanta-
tion period, thereby confirming the critical size of thedefect
FIGURE 1. Overview of the rat femoral defect after 8 weeks by micro-CT. Micro-CT evaluation after 8 weeks of implantation showed (A) absence
of complete bridging of the empty defect confirming its critical size (a, two ends of the bone; b, marrow cavity; and d, the actual defect), (B)
maintenance of the shape of the HA implant, and (C) rounding of the edges of the b-TCP implant, suggestive of the more pronounced degrada-
tion of b-TCP as compared to HA. The two ends of the bone (a); marrow cavity (b); and the actual defect (d).
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[Fig. 1(A)]. Micro-CT scans of defects grafted with HA and
b-TCP some limited bone formation originating from the
proximal and distal host bone and areas of direct bone-
implant contact were limited. Differences in resorption
between HA and b-TCP were noted in the defects grafted
with the two ceramics. Whereas HA retained its cylindrical
shape [Fig. 1(B)], b-TCP clearly showed signs of degradation
in the regions closest to the host bone bed [Fig. 1(C)].
Histology and histomorphometry
In line with the micro-CT scan findings, histology of the empty
defects confirmed the critical size of the defect. The defect
site was filled with loosely organized fibrous tissue, and no
bridging of the defect occurred [Fig. 2(A)]. Rounding of the
edges and loss of structure were observed in the b-TCP after
8 weeks [Fig. 2(B)], in contrast to HA implants that retained
the original shape [Fig. 2(C)]. Direct contact between HA or
b-TCP and the proximal and distal femoral bone was limited,
fibrous tissue had formed at the majority of the interface.
Initiation and progression of inflammation for HA and
b-TCP was determined by histology after 5 and 12 days and
TABLE I. Characterization of the Calcium Phosphate
Ceramics In Vitro
HA b-TCP




1250 C 1050 C
Macroporosity 660% 660%
Microporositya Low (6 5%) High (6 15%)
Surface area Low (<0.5 m2/g) High (1.2 m2/g)
aVolume percentage of micropores smaller than 10 lm within the
ceramic.
FIGURE 2. Overview of the rat femoral defect after 8 weeks by histology. Histology findings at 8 weeks were very similar to the micro-CT scan
findings. At 8 weeks, (A) incomplete bridging of the empty defect with presence of poorly organized fibrous tissue between the two cut ends of
the femur confirmed the critical size of the defect, (B) presence of rounded edges in the b-TCP (marked by white arrows), suggested a pro-
nounced degradation at these sites, and (C) maintenance of the cylindrical shape of the HA ceramic suggested limited degradation. Islands of
bone were seen in all the b-TCP and some HA ceramics (encircled areas). The two ends of the bone (a); marrow cavity (b); muscle surrounding
the bone and defect site (c); the actual defect (d); and screws used to hold the PEEK plate in place over the defect (e). [Color figure can be
viewed in the online issue, which is available at wileyonlinelibrary.com.]
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6 and 8 weeks. Clusters of round cells, highly suggestive of
inflammatory cells such as monocytes or lymphocytes were
found within the pores of both the HA and the b-TCP
implants at 5 and 12 days [Fig. 3(A–F)]. No obvious differ-
ence was observed between the two ceramics. These cells
were not seen in either ceramic after 6 weeks. Instead,
small islands of new bone formation were observed in the
pores of both HA [Fig. 4(A,B)] and b-TCP [Fig. 4(C,D)].
These results suggested that the cellular infiltration which
was probably of inflammatory origin subsided between 12
days and 6 weeks of implantation, whereas the bone forma-
tion was initiated during this time.
The amount of bone increased between 6 and 8 weeks for
both HA and b-TCP. The insets in Figure 4(E,F) demonstrate
the mineralized matrix, bone lining cells and embedded
osteocytes which histologically characterize bone. New bone
formation was observed in all b-TCP implants (9/9) and in
seven HA implants (7/9). Total amount of bone formed in
defects grafted with b-TCP ceramic was significantly more
than that formed in defects grafted with HA (3.6 6 2.1% vs
1.4 6 1.6%, respectively, of the available pore area was filled
with newly formed bone; Fig. 5(A)]. However, no significant
difference was found in the amount of bone that formed in
the central area of the b-TCP or HA implants, where chances
of bone ingrowth from the host bone bed were lowest.
Although 3.1 6 2.5% of the available pore area in the central
part of the defect was filled with newly formed bone in b-TCP,
the corresponding value for HA was 2.5 6 2.4% [Fig. 5(B)].
Analysis of the fluorochrome markers showed that both
CG and XO label were found in areas adjacent to host bone
FIGURE 3. Histological overview of the b-TCP and HA ceramics after 5 and 12 days. Rounded cells, probably of inflammatory origin within the
pores of the b-TCP and HA ceramics after 5 days (A and B, respectively) and after 12 days (C and D, respectively). A 403 magnified view of
the inflammatory cells in the b-TCP ceramic after 12 days (E) and an enlargement of the black square area (F). [Color figure can be viewed in the
online issue, which is available at wileyonlinelibrary.com.]
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FIGURE 4. Histological overview of b-TCP and HA ceramics after 6 and 8 weeks. Absence of the inflammatory cells with concomitant presence
of small islands of new bone within the HA (A) and b-TCP (C) ceramics after 6 weeks. Magnified view of bone formed within the pores of the
HA (B) and b-TCP implants (D). Note the presence of osteocytes (white arrows) embedded in the pink matrix and the bone lining cells (dotted
black arrows). The rest of the pore was filled by cells with elongated nuclei (fibrous tissue marked by black arrows). After 8 weeks, again islands
of new bone were observed in both b-TCP (E) and HA (F). The inset images show magnified views of the newly formed bone. Note the presence
of osteocytes, bone lining cells, and matrix. [Color figure can be viewed in the online issue, which is available at wileyonlinelibrary.com.]
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bed, as well as in the central area of the defect [denoted by
the rectangle in Fig. 5(B)], suggesting early bone deposition
throughout the implanted ceramics. Presence of CG label in
the two ceramics indicated that bone formation had started
in both HA and b-TCP earlier than 4 weeks postimplantation
[Fig. 6(A,B)]. Continued deposition and remodeling of bone
FIGURE 5. Quantification of bone formed within the pores of HA and b-TCP cylinders. The amount of bone formed was determined in the avail-
able pore area of the total implant (A) and in the center of the implant (B). The black rectangle in both the insets represents the area of the
implant in which the new bone deposition was calculated. The error bars represent the standard deviation. Statistical analysis using the
Student’s paired t test. *p < 0.05. [Color figure can be viewed in the online issue, which is available at wileyonlinelibrary.com.]
FIGURE 6. Dynamics of bone deposition within the two ceramics. Fluorescence microscopy images (original magnification 310) of the fluoro-
chrome markers in the center of the b-TCP (A) and HA (B) ceramics. C represents a 34 time magnified image of the two ends of the femur with
the intervening defect (d). CG, calcein green; XO, xylenol orange; SC, ceramic scaffold. [Color figure can be viewed in the online issue, which is
available at wileyonlinelibrary.com.]
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at 8 weeks in the two CaP ceramics was suggested by the
presence of the XO label. In the empty defect, fluorochrome
markers were only observed at the two ends of the defect,
close to the host bone bed, indicating bone deposition and
remodeling as a part of the body’s intrinsic healing process
[Fig. 6(C)].
DISCUSSION
The present study aimed to determine bone formation in
clinically more relevant critical femoral bone defects in rats
after grafting with open porous b-TCP and HA ceramics,
which were previously shown to significantly differ in their
osteoinductive potential.16 Our current findings indicated
that at the selected implantation site, the amount of bone
formed in both ceramics was limited and not sufficient to
bridge the defect within the implantation period of 8 weeks.
Nevertheless, the b-TCP ceramic which had previously dem-
onstrated a superior osteoinductivity as compared to the
HA upon heterotopic implantation, also resulted in a compa-
ratively greater amount of bone within the critical-sized
bone defect used here. Further, based on the histological
analysis of the inflammatory response elicited postimplanta-
tion, we observed that inflammation in both b-TCP and HA
subsides between 12 days and 6 weeks while bone forma-
tion was initiated between 12 days and 4 weeks. Consider-
ing that no obvious differences between the two ceramics
were observed regarding the timing and the extent of
inflammation, neither one of these parameters could be
related to the difference in the amount of bone formed.
Comparison between ceramics with known differences
osteoinductivity in orthotopic defects is limited. Gosain
et al.17,18 demonstrated that HA-TCP cement with higher
osteoinductive potential showed superior performance in a
critical-sized calvarial sheep model as compared to the non
osteoinductive pure HA cement after 1 year. In another
study, two BCP ceramics, having similar chemical composi-
tion but significantly different microstructure were com-
pared intramuscularly as well as in an iliac wing defect in
goats after 3 months.22 The BCP ceramic with a greater sur-
face area as a result of a higher microporosity was more
osteoinductive at the heterotopic location and performed
significantly better in the iliac wing defect than the non
osteoinductive BCP. Superiority in osteoinductive potential
of the BCP ceramic was also reflected in the larger amount
of bone formed after 3 months in a decorticated transverse
process model in goats that represents the first stages of
spinal fusion.23
Bone formation observed after implantation of b-TCP
and HA ceramics in rats femurs was rather limited com-
pared to bone formation observed after implantation of
these ceramics in dogs and goats,16 even though bone heal-
ing capacity is generally believed to be less in larger ani-
mals.24 Compared to these studies, we used a relatively
short implantation period, but this is not believed to be a
likely explanation for the low amounts of bone observed as
we19 and others25,26 have shown substantial bone healing
responses in femoral bone defects within 8 weeks. However,
bone healing capacity is also strongly affected by local bio-
logical and biomechanical factors at the site of implantation.
Implantation in a segmental bone defect, a weight-bearing
orthotopic site, will greatly increase the influence of biome-
chanical factors on bone healing, whereas biomechanical
factors play only a minimal role in ectopic (intramuscular or
paraspinal) implantation sites. Both the loading over the
defect, as well as the fixation conditions used, may have
diminished bone formation by hampering endochondral
ossification. However, these conditions mimic clinical rele-
vant bone defects that require bone grafting, as most bone
defects result from fractures of long bones. So this weight-
bearing orthotopic bone defect might be more suitable for
making claims toward the use of these ceramics in specific
clinical applications, whereas the ectopic models provide
insight in osteoinductive capacity and might help to unravel
underlying mechanisms.
The greater amount of bone formation upon implanta-
tion of b-TCP compared to HA, cannot be solemnly attrib-
uted to a higher osteoinductive potential of b-TCP. For
example, it cannot be excluded that higher microporosity
resulting in a twelve times greater surface area positively
affected osteoconductive potential of b-TCP. In fact, our find-
ing of a significantly higher percentage of bone in the avail-
able pore area in the total region of interest without
significant difference within the central portion of the
implant, points to the fact that the difference in bone forma-
tion between the two CaP ceramics was in the peripheral
area. As osteoconduction per definition proceeds from the
host bone bed, bone in the periphery of the implant is likely
the result of osteoconduction. In the central area of the
implant, the material is not in direct contact with the osteo-
genic cells present in the host bone bed. However, without
studies that determine the origin of new bone formation, it
is difficult to prove that the bone formed within the central
pores of the implant is due to direct differentiation of the
inducible osteoprogenitor cells present in the bone marrow
or the surrounding muscle, thus osteoinduction.
Although our results confirm bone healing capacity is
greater with b-TCP as compared to HA, dynamics of inflam-
mation were equal for the two ceramics. b-TCP and HA
resulted in a inflammatory reaction during the first 2 weeks,
as is generally seen within bone healing,27 which subsides
by 6 weeks. Because we compared two ceramics with differ-
ent physicochemical properties (Table I), their behavior
upon a inflammatory environment may be different (pH
changes and calcium and phosphate ion release). However,
this became not apparent in the dynamics of bone forma-
tion, because fluorochrome analysis revealed that bone
formation had started at around 4 weeks in both b-TCP
and HA.
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